Search
for
Sort by
Research 91–120 of 1000+
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- When bugs and drugs conspire: driving acneiform skin toxicity
- Dermatoses of Pregnancy
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- When Diet Trends Go Viral: Cutaneous Manifestations of Social Media-Driven Fad Diets and Supplements
- Co-existence of Systemic Lupus Erythematosus and Celiac Disease: A Case Report
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Skin Manifestations of Rheumatological Diseases
- Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy
- Cutaneous manifestations associated with immune checkpoint inhibitors
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Immediate and Delayed Complications of Dexamethasone Cyclophosphamide Pulse (DCP) Therapy
- Dermatological history and examination
- Lupus erythematosus: systemic and cutaneous manifestations
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Malarone® induced pancreatitis and alopecia in a dog: a case report
- Pityriasis rubra pilaris: a rare inflammatory dermatosis
- Rare Combination of Adverse Effects Associated With Lamotrigine Treatment
- Anxiety in the Medically Ill: A Systematic Review of the Literature
- NEW YORK DERMATOLOGICAL SOCIETY
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Cutaneous manifestations of systemic lupus erythematosus
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment